Observational studyInternational journal of hematology2020

Treatment outcomes of chronic-phase chronic myeloid leukemia with resistance and/or intolerance to a 1st-line tyrosine kinase inhibitor in Japan: the results of the New TARGET study 2nd-line.

Masatoshi Sakurai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.